AOD-9604 + CJC-1295 + Ipamorelin 12mg Blend
Components: AOD-9604 + CJC-1295 (No DAC) + Ipamorelin
A triple-action fat loss and GH secretagogue blend combining AOD-9604 (6mg), CJC-1295 No DAC (3mg), and Ipamorelin (3mg) in a 12mg vial. Targets fat metabolism and pulsatile GH release.
Blend Composition
This is a single pre-mixed vial — one reconstitution for all components.
Synergy Explanation
AOD-9604 is an HGH fragment (177–191) that stimulates lipolysis and inhibits lipogenesis without IGF-1 elevation. CJC-1295 No DAC acts as a GHRH analogue to prime pituitary GH release. Ipamorelin selectively activates the ghrelin receptor to trigger GH pulses with minimal cortisol or prolactin elevation. The combination drives fat metabolism through both direct lipolysis (AOD-9604) and enhanced GH secretion (CJC-1295 + Ipamorelin).
Reconstitution Guide
-
Allow the vial to reach room temperature for 5 minutes before handling.
-
Draw 3.0 mL of bacteriostatic water into a sterile syringe.
-
Sterilize the vial stopper with an alcohol swab and allow to dry.
-
Inject the BAC water slowly down the inside wall of the vial.
-
Gently swirl or roll until fully dissolved. Do not shake.
-
Label with reconstitution date and store refrigerated at 2u20138 u00b0C (35.6u201346.4 u00b0F).
Always use bacteriostatic water — not sterile water — to extend shelf life of your reconstituted blend.
Dosage Protocols
| Protocol | Dose | Frequency | Duration | Route | Notes |
|---|---|---|---|---|---|
| Initiation Phase (Week 1) | AOD: 200 mcg / CJC-1295: 100 mcg / Ipamorelin: 100 mcg once daily | Once daily | 1 week | SubQ | Begin at the lower initiation dose. At 4 mg/mL, the blend delivers AOD/CJC/Ipamorelin in a 2:1:1 ratio per unit volume. |
| Maintenance Phase (Week 2 onwards) | AOD: 400 mcg / CJC-1295: 200 mcg / Ipamorelin: 200 mcg once daily | Once daily | 12u201316 weeks | SubQ | Advance to maintenance dosing after the first week if tolerated. Administer in the evening to coincide with natural nocturnal GH pulses. |
Storage Instructions
Lyophilized (Dry)
Store at ≤−15 °C (5 °F). For long-term storage, ≤−50 °C (−58 °F) preferred.
Reconstituted
Refrigerate at 2–8 °C (35.6–46.4 °F). Use within 3–4 weeks. Do not freeze after reconstitution.
Keep the reconstituted vial refrigerated at all times. Protect from light.
Supplies Needed
-
Bacteriostatic water (BAC water) 10 mL vial
-
Insulin syringes (U-100) 0.5 mL, 29u201331 gauge
-
Alcohol swabs For stopper and injection site sterilization
Potential Side Effects
Generally well tolerated. Possible transient water retention from elevated GH. Mild hunger increase possible from Ipamorelin. Injection site reactions may occur.
Questions about AOD-9604 + CJC-1295 + Ipamorelin 12mg Blend
AOD-9604 makes up 50% (6mg), CJC-1295 No DAC 25% (3mg), and Ipamorelin 25% (3mg) of the 12mg total vial.
Evening administration is recommended to align Ipamorelin's GH pulse with the natural nocturnal GH surge. Avoid carbohydrates for 90 minutes before injection for best results.
Research Use Disclaimer
This content is for educational purposes only and does not constitute medical advice. For research use only.